TUBA3C
Basic information
Region (hg38): 13:19173772-19181824
Previous symbols: [ "TUBA2" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TUBA3C gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 22 | 22 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 22 | 0 | 0 |
Variants in TUBA3C
This is a list of pathogenic ClinVar variants found in the TUBA3C region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
13-19173879-T-A | not specified | Uncertain significance (Apr 25, 2023) | ||
13-19173889-C-G | not specified | Uncertain significance (May 30, 2023) | ||
13-19173891-G-C | not specified | Uncertain significance (Dec 20, 2023) | ||
13-19173924-T-G | not specified | Uncertain significance (Oct 29, 2021) | ||
13-19173951-C-A | not specified | Uncertain significance (Apr 08, 2022) | ||
13-19174098-C-T | not specified | Uncertain significance (Feb 06, 2023) | ||
13-19174101-T-C | not specified | Uncertain significance (Jan 26, 2023) | ||
13-19176967-C-T | not specified | Uncertain significance (Jan 31, 2022) | ||
13-19176980-T-C | not specified | Uncertain significance (Dec 27, 2023) | ||
13-19176994-G-A | not specified | Uncertain significance (Aug 21, 2023) | ||
13-19177121-C-T | not specified | Uncertain significance (Feb 13, 2023) | ||
13-19177148-C-T | not specified | Uncertain significance (Apr 10, 2023) | ||
13-19177321-C-T | not specified | Uncertain significance (Aug 05, 2023) | ||
13-19177342-C-T | not specified | Uncertain significance (Mar 31, 2024) | ||
13-19177429-T-C | not specified | Uncertain significance (May 18, 2023) | ||
13-19177454-C-T | not specified | Uncertain significance (Jan 30, 2024) | ||
13-19177535-C-T | not specified | Uncertain significance (Apr 15, 2024) | ||
13-19177589-G-C | not specified | Uncertain significance (Apr 09, 2024) | ||
13-19177606-G-A | not specified | Uncertain significance (Mar 01, 2024) | ||
13-19178260-G-A | not specified | Uncertain significance (Dec 15, 2023) | ||
13-19179392-C-G | not specified | Uncertain significance (Mar 12, 2024) | ||
13-19179442-A-G | not specified | Uncertain significance (Aug 11, 2022) | ||
13-19179479-T-C | not specified | Uncertain significance (Feb 21, 2024) | ||
13-19179508-C-T | not specified | Uncertain significance (Feb 10, 2022) | ||
13-19179518-C-T | not specified | Uncertain significance (Mar 18, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TUBA3C | protein_coding | protein_coding | ENST00000400113 | 5 | 8083 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00457 | 0.968 | 125689 | 0 | 58 | 125747 | 0.000231 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.78 | 204 | 289 | 0.706 | 0.0000195 | 2935 |
Missense in Polyphen | 87 | 125.21 | 0.69485 | 1381 | ||
Synonymous | -2.78 | 162 | 123 | 1.32 | 0.00000918 | 913 |
Loss of Function | 1.93 | 6 | 13.7 | 0.438 | 6.73e-7 | 159 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000720 | 0.000720 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000489 | 0.000489 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000185 | 0.000167 |
Middle Eastern | 0.000489 | 0.000489 |
South Asian | 0.000294 | 0.000294 |
Other | 0.000655 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: Tubulin is the major constituent of microtubules. It binds two moles of GTP, one at an exchangeable site on the beta chain and one at a non-exchangeable site on the alpha chain.;
- Pathway
- Tight junction - Homo sapiens (human);Phagosome - Homo sapiens (human);Gap junction - Homo sapiens (human);Pathogenic Escherichia coli infection - Homo sapiens (human);Apoptosis - Homo sapiens (human);Pathogenic Escherichia coli infection;Parkin-Ubiquitin Proteasomal System pathway;stathmin and breast cancer resistance to antimicrotubule agents;downregulated of mta-3 in er-negative breast tumors;Post-translational protein modification;Metabolism of proteins;Chaperonin-mediated protein folding;Formation of tubulin folding intermediates by CCT/TriC;Carboxyterminal post-translational modifications of tubulin;Protein folding;Prefoldin mediated transfer of substrate to CCT/TriC;Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding;Post-chaperonin tubulin folding pathway
(Consensus)
Recessive Scores
- pRec
- 0.194
Intolerance Scores
- loftool
- 0.398
- rvis_EVS
- -0.57
- rvis_percentile_EVS
- 18.9
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.427
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.780
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- microtubule cytoskeleton organization;mitotic cell cycle;cytoskeleton organization;microtubule-based process
- Cellular component
- cytoplasm;microtubule
- Molecular function
- GTPase activity;structural constituent of cytoskeleton;GTP binding